These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2986348)

  • 1. [Binary ethyleneimine as an inactivator of the foot-and-mouth disease virus].
    Tekerlekov P; Veleva E
    Vet Med Nauki; 1985; 22(3):3-8. PubMed ID: 2986348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
    Bahnemann HG
    Arch Virol; 1975; 47(1):47-56. PubMed ID: 167679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined method (suspension-monolayer) of preparing an inactivated foot-and-mouth disease vaccine].
    Genov I; Tivchev G; Veleva E; Tekerlekov P; Shopov I
    Vet Med Nauki; 1981; 18(5):57-63. PubMed ID: 6275604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative testing of the quality of foot-and-mouth disease vaccines prepared with different virus inactivators].
    Dilovski M; Tekerlekov P
    Vet Med Nauki; 1983; 20(5-6):41-5. PubMed ID: 6318423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines.
    Burrage T; Kramer E; Brown F
    Vaccine; 2000 May; 18(22):2454-61. PubMed ID: 10738103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine.
    Aarthi D; Ananda Rao K; Robinson R; Srinivasan VA
    Biologicals; 2004 Sep; 32(3):153-6. PubMed ID: 15536046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P; Guerche J; Galampoix J; Prunet P
    Dev Biol Stand; 1976; 35():301-10. PubMed ID: 198300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of viruses by aziridines.
    Burrage T; Kramer E; Brown F
    Dev Biol (Basel); 2000; 102():131-9. PubMed ID: 10794100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attempts to adapt BNK cells to cultivation in suspension and study of the antigenic properties of foot-and-mouth diseases viruses obtained from them].
    Mitev G; Tekerlekov P; Nikolova E
    Vet Med Nauki; 1976; 13(7):91-5. PubMed ID: 189487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of temperature and inactivators on strains of foot-and-mouth disease virus in Colombia].
    Gómez GJ; Doel TR
    Rev Latinoam Microbiol; 1984; 26(1):21-6. PubMed ID: 6091209
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of viruses in serum with binary ethyleneimine.
    Bahnemann HG
    J Clin Microbiol; 1976 Feb; 3(2):209-10. PubMed ID: 3517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenic properties of foot-and-mouth vaccines].
    Tekerlekov P; Nikolova E; Dilovski M
    Vet Med Nauki; 1983; 20(5-6):46-51. PubMed ID: 6318424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative trial of the immunogenic properties of commercial foot-and-mouth virus strains].
    Tekerlekov P; Nikolova E
    Vet Med Nauki; 1981; 18(1):19-26. PubMed ID: 6272473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of indirect complement fixation test for studying foot and mouth disease virus].
    Tekerlekov P; Mitev G
    Vet Med Nauki; 1976; 13(7):35-41. PubMed ID: 189484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines.
    Brown F
    Dev Biol Stand; 1991; 75():37-41. PubMed ID: 1665462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.